Shandong Xinhua Pharmaceutical Co's EBIT per Share for the
three
months ended in Mar. 2026 was $0.26.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.79.
During the past 12 months, the average EBIT per Share Growth Rate of Shandong Xinhua Pharmaceutical Co was -19.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -7.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -3.40% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 9.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Shandong Xinhua Pharmaceutical Co's EBIT per Share or its related term are showing as below:
SHNXY'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -34.8 Med: 4.1 Max: 46
Current: -7.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Shandong Xinhua Pharmaceutical Co was 46.00% per year. The lowest was -34.80% per year. And the median was 4.10% per year.
SHNXY's 3-Year EBIT Growth Rate is ranked worse than 73.09% of 810
companies
in the Drug Manufacturers industry
Industry Median: 7.5
vs SHNXY: -7.40
Shandong Xinhua Pharmaceutical Co (OTCPK:SHNXY) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Shandong Xinhua Pharmaceutical Co EBIT per Share Related Terms
Shandong Xinhua Pharmaceutical Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Xinhua Pharmaceutical Co EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.79
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Xinhua Pharmaceutical Co (SHNXY) has a EBIT per Share of $0.79 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Shandong Xinhua Pharmaceutical Co and its competitors. According to the industry distribution chart, Shandong Xinhua Pharmaceutical Co ranks #592 out of 810 companies in the Drug Manufacturers industry, placing it in the top 73.1%.
Is Shandong Xinhua Pharmaceutical Co's EBIT per Share too high?
Shandong Xinhua Pharmaceutical Co's current EBIT per Share is $0.79. The Drug Manufacturers industry median EBIT per Share is 7.50. Shandong Xinhua Pharmaceutical Co's value of $0.79 is 89.5% below this industry median. Based on the distribution chart, Shandong Xinhua Pharmaceutical Co ranks #592 out of 810 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Shandong Xinhua Pharmaceutical Co has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Xinhua Pharmaceutical Co's EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shandong Xinhua Pharmaceutical Co ranks #592 out of 810 companies for EBIT per Share. This places Shandong Xinhua Pharmaceutical Co in the lower half of its industry. The industry median EBIT per Share is 7.50. Shandong Xinhua Pharmaceutical Co's value of $0.79 is 89.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.50, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Xinhua Pharmaceutical Co's current EBIT per Share of $0.79 is 89.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Shandong Xinhua Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Xinhua Pharmaceutical Co's current EBIT per Share is $0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Xinhua Pharmaceutical Co stock overvalued right now?
Shandong Xinhua Pharmaceutical Co (SHNXY) has a current EBIT per Share of $0.79. The stock's GF Value™ is $21.89, compared to a current price of $18.19 — trading 16.9% below its estimated fair value. The current EBIT per Share is $0.79 and 89.5% below the Drug Manufacturers industry median of 7.50. Shandong Xinhua Pharmaceutical Co's overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Shandong Xinhua Pharmaceutical Co (SHNXY), the current EBIT per Share is $0.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Xinhua Pharmaceutical Co (SHNXY) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Xinhua Pharmaceutical Co stock appears to be undervalued.
The current stock price of $18.19 is trading 16.9% below its estimated GF Value™ of $21.89.
Key valuation signals for SHNXY:
EBIT per Share: $0.79
GF Value™: $21.89 vs. price of $18.19 (16.9% below fair value)
Industry Position: 89.5% below the Drug Manufacturers median (#592 of 810)
No single metric tells the full story. See the SHNXY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Xinhua Pharmaceutical Co Business Description
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates various segments namely Chemical raw materials, Preparations, Pharmaceutical intermediates and other products. The company is mainly engaged in the business of development, manufacture and sale of bulk pharmaceuticals, preparations and chemical products.
75GF Score
Get the complete analysis for SHNXY
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHNXY has been successfully added to your 
